← Back to catalogue

OPTIGEN® Negative Control Reagent

FDA UDI

Class II (US FDA UDI)

by Minaris Medical America, Inc.

Identity

Trade Name
OPTIGEN® Negative Control Reagent FDA UDI
Generic Name
Allergen-specific/total immunoglobulin E (IgE) antibody IVD, control FDA UDI
Device Name
OPTIGEN Negative Control FDA UDI
Model / Reference
82062 FDA UDI
Description
OPTIGEN Negative Control FDA UDI

Identifiers

Catalog Number
82062 FDA UDI
Primary DI / UDI-DI
00813382010099 FDA UDI
510(k) Number
K051677 FDA UDI
FDA Product Code
DGC FDA UDI
GMDN Term
Allergen-specific/total immunoglobulin E (IgE) antibody IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5510 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Allergen-specific/total immunoglobulin E (IgE) antibody IVD, control

OPTIGEN® Negative Control Reagent by Minaris Medical America, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Allergen-specific/total immunoglobulin E (IgE) antibody IVD, control.

Cleared under the same submission

K051677 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Minaris Medical America, Inc.

Sources (1)

  • FDA UDI f00fe926-c0e8-4b3a-a211-d7e7ff11592f 37 fields · synced May 30, 2026